The board of directors exercises authorizations to issue and repurchase C-shares, and converts C-shares to common shares
Moberg Pharma AB (publ) today announces that the board of directors exercises authorizations to issue and repurchase C-shares, and converts C-shares to common shares, to secure the company’s commitments under incentive programme.The annual general meeting of Moberg Pharma AB (publ) on 16 May 2023 resolved – for the purpose of ensuring that the company can fulfil its commitments under the long-term incentive programme LTI 2023 resolved by the annual general meeting – to authorize the board of directors to resolve on a directed share issue of redeemable- and convertible class C shares. The